These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24321981)

  • 1. Regulatory challenges associated with conducting multicountry clinical trials in resource-limited settings.
    Ndebele P; Blanchard-Horan C; Shahkolahi A; Sanne I
    J Acquir Immune Defic Syndr; 2014 Jan; 65 Suppl 1(0 1):S29-31. PubMed ID: 24321981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
    Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
    Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory approvals in a large multinational clinical trial: the ESPRIT experience.
    McNay LA; Tavel JA; Oseekey K; McDermott CM; Mollerup D; Bebchuk JD;
    Control Clin Trials; 2002 Feb; 23(1):59-66. PubMed ID: 11852166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union.
    Ramirez I
    Ger Med Sci; 2015; 13():Doc21. PubMed ID: 26633964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health.
    Neaton JD; Babiker A; Bohnhorst M; Darbyshire J; Denning E; Frishman A; Grarup J; Larson G; Lundgren J
    Clin Trials; 2010 Dec; 7(6):705-18. PubMed ID: 20729252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre drug trials, ethics approval and death of patients.
    Millar JA
    Intern Med J; 2008 Apr; 38(4):298-9; author reply 299. PubMed ID: 18380711
    [No Abstract]   [Full Text] [Related]  

  • 7. Human-subjects research: trial and error.
    Ledford H
    Nature; 2007 Aug; 448(7153):530-2. PubMed ID: 17671478
    [No Abstract]   [Full Text] [Related]  

  • 8. A case study of a single ethics committee for multicentre trials.
    Olver IN; Falleiro SJ; Marson ML; Bishop JF
    Med J Aust; 2011 Nov; 195(10):582-3. PubMed ID: 22107003
    [No Abstract]   [Full Text] [Related]  

  • 9. Who watches the watchmen?
    Nature; 2011 Aug; 476(7359):125. PubMed ID: 21833048
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for promoting international multi-site clinical trials-from a viewpoint of ethics review.
    Nakada H; Hasthorpe S; IJsselmuiden C; Kombe F; Ba M; Matei M; Nakamura K; Ushirozawa N; Fujiwara Y; Tashiro S
    Dev World Bioeth; 2019 Dec; 19(4):192-195. PubMed ID: 31513337
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical issues raised by cluster randomised trials conducted in low-resource settings: identifying gaps in the
    Mtande TK; Weijer C; Hosseinipour MC; Taljaard M; Matoga M; Goldstein CE; Nyambalo B; Rosenberg NE
    J Med Ethics; 2019 Jun; 45(6):388-393. PubMed ID: 31189724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growing pains: central review board project still developing.
    Randal J
    J Natl Cancer Inst; 2003 May; 95(9):636-7. PubMed ID: 12734305
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges of international oncology trial collaboration-a call to action.
    Tang M; Joensuu H; Simes RJ; Price TJ; Yip S; Hague W; Sjoquist KM; Zalcberg J
    Br J Cancer; 2019 Oct; 121(7):515-521. PubMed ID: 31378784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
    Tuffs A
    BMJ; 2012 Oct; 345():e6640. PubMed ID: 23033377
    [No Abstract]   [Full Text] [Related]  

  • 15. StatBite: Key findings from the "Impact on clinical research of European legislation" report.
    J Natl Cancer Inst; 2010 Mar; 102(5):293. PubMed ID: 20173122
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward protecting the safety of participants in clinical trials.
    Califf RM; Morse MA; Wittes J; Goodman SN; Nelson DK; DeMets DL; Iafrate RP; Sugarman J
    Control Clin Trials; 2003 Jun; 24(3):256-71. PubMed ID: 12757992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. India tightens regulation of clinical trials to safeguard participants.
    Chatterjee P
    BMJ; 2013 Feb; 346():f1275. PubMed ID: 23440346
    [No Abstract]   [Full Text] [Related]  

  • 18. [New regulation for multicenter clinical trials and its repercussions on the function of current clinical trial ethics committees].
    García Herrera JL
    Rev Esp Quimioter; 2003 Dec; 16(4):383-4. PubMed ID: 14961130
    [No Abstract]   [Full Text] [Related]  

  • 19. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
    Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
    Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ethics approval process for multisite research studies in Australia: changes sought by the Australian Genomics initiative.
    Haas MA; Boughtwood TF; Quinn MC;
    Med J Aust; 2019 Nov; 211(10):440-444.e1. PubMed ID: 31734945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.